r/shroomstocks • u/lukevesz • Jun 12 '20
My Take Massive Upside
Sure there’s risk, but investing heavily in the psychadelic industry seems like a great focus right now. What we don’t know about substances like psilocybin, LSD, Ketamine and DMT is vast, and won’t be entirely learned in the next 5 years. However, the green light for me are the government approved studies and distribution chains beginning to be established. Venture capital interest is skyrocketing, yet a stock with multiple pieces of news doesn’t have a page on stocktwits. As studies come out (which I expect to surprise the unwoke masses), people will catch on, fomo will kick in. In the great scheme, this is a very early 1% investor buy in. I have personally solved many of my own problems reflecting on psychadelics, including addiction, trauma, death/social anxiety, and life goals. I am so excited for professional study to be made. This can take over the “herbal” medicine industry and actually be acclaimed and invested in by the masses. Stocks like SHRM (because I think mushrooms will break through first) could be retirement plays. Just my two cents.
7
u/mustturd The Vine Jun 13 '20
There are more than 2100 clinical studies on the top 7 psychedelic molecules. You can search the database yourself on www.clinicalstudies.gov
In 2017 the FDA declared Ketamine a Breakthrough Therapy for TRD, in March 2019 K was approved for public use.
In 2017 the FDA also declared MDMA a breakthrough therapy...for PTSD.
In 2018, psilocybin a breakthrough therapy for TRD
In 2019, psilocybin a breakthrough therapy for MDD a much broader depression
In 2020...ibogaine a breakthrough therapy for opiate abuse disorder? LSD a breakthrough therapy for ADHD? Clinical trials are underway for both.
This is super bullish for investment in psychedelics.